Evan Schwartz

Evan Schwartz, CFA, serves as the Co-Founder of Sinea Therapeutics and has extensive experience in the biotechnology and finance sectors. Previous roles include serving as a Consultant and Entrepreneur in Residence at Roivant Sciences, as well as holding the position of Principal at ArcLight Capital Partners. Additionally, Evan Schwartz worked as an Associate at DC Energy, contributing to a diverse professional background that combines entrepreneurship and financial expertise.